Literature DB >> 6774019

Production of a suppressor factor by human adherent cells treated with mycobacteria.

A A Wadee, R Sher, A R Rabson.   

Abstract

Human peripheral blood mononuclear cell (MN) proliferation and lymphokine production induced by mitogen could be inhibited by heat killed whole mycobacteria. The inhibition was induced by a wide variety of mycobacteri but not by other Gram-positive or Gram-negative organisms or by latex particles. Proliferation and lymphokine production by adherent cell-depleted lymphocytes was not inhibited by these organisms. Adherent cells treated with mycobacteria had the ability to inhibit lymphocyte blastogenesis when co-cultured with the lymphocytes. the inhibitory effect of these adherent cells was due to the release of a heat stable, nondialyzable suppressor cells. These latter cells, which were T gamma cells, could inhibit the blastogenic ability of normal lymphocytes activated by mitogens. The results suggest that in situations of high mycobacterial load, adherent cells are activted to release a suppressor factor that will activate lymphocytes to become suppressor cells. This mechanism may explain the anergy associated with lepromatous leprosy or advanced tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6774019

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Antigen-specific B-cell unresponsiveness induced by chronic Mycobacterium avium subsp. paratuberculosis infection of cattle.

Authors:  W R Waters; J R Stabel; R E Sacco; J A Harp; B A Pesch; M J Wannemuehler
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Deficient immune interferon production in tuberculosis.

Authors:  J K Onwubalili; G M Scott; J A Robinson
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

3.  Inhibition of mitogenesis induced by phytohemagglutinin and Lens culinaris lectin in adherent-cell supernatants treated with protein extract of Mycobacterium tuberculosis.

Authors:  C Parra; L F Montaño; M Huesca; I Rayón; K Willms; F Goodsaid
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

4.  Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide.

Authors:  A Molloy; G Gaudernack; W R Levis; Z A Cohn; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  Inhibition of the proliferative response of peripheral blood lymphocytes to mycobacterial or fungal antigens by co-stimulation with antigens from various mycobacterial species.

Authors:  G M Bahr; G A Rook; J L Stanford
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

6.  Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes.

Authors:  J Gercken; J Pryjma; M Ernst; H D Flad
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Production of a suppressor factor by human adherent cells treated with Mycobacterium tuberculosis: absence in systemic lupus erythematosus.

Authors:  A A Wadee; A J Gear; A R Rabson
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

8.  Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.

Authors:  G Kaplan; E P Sampaio; G P Walsh; R A Burkhardt; T T Fajardo; L S Guido; A de Miranda Machado; R V Cellona; R M Abalos; E N Sarno
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Comparative effects of Mycobacterium avium glycopeptidolipid and lipopeptide fragment on the function and ultrastructure of mononuclear cells.

Authors:  M Pourshafie; Q Ayub; W W Barrow
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

10.  T-cell lung granulomas induced by sepharose-coupled Mycobacterium tuberculosis protein antigens: immunosuppressive phenomena reversed with cyclophosphamide and indomethacin.

Authors:  R Hernández-Pando; H Orozco; R Mancilla
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.